Search

Author/Creator Shere, Mike

1. Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial. Issue 1 (January 2018)

Authors:
Colleoni, Marco; Luo, Weixiu; Karlsson, Per; Chirgwin, Jacquie; Aebi, Stefan; Jerusalem, Guy; Neven, Patrick; Hitre, Erika; Graas, Marie-Pascale; Simoncini, Edda; Kamby, Claus; Thompson, Alastair; Loibl, Sibylle; Gavilá, Joaquín; Kuroi, Katsumasa; Marth, Christian; Müller, Bettina; O'Reilly, Seam...
Journal:
Lancet oncology
Issue:
Volume 19:Issue 1(2018)
Page Start:
127
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Referral patterns, cancer diagnoses, and waiting times after introduction of two week wait rule for breast cancer: prospective cohort study. Issue 7614 (13th July 2007)

Authors:
Potter, Shelley; Govindarajulu, Sasi; Shere, Mike; Braddon, Fiona; Curran, Geoffrey; Greenwood, Rosemary; Sahu, Ajay K; Cawthorn, Simon J
Journal:
BMJ
Issue:
Volume 335:Issue 7614(2007)
Page Start:
288
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗